Match!
Jaime Hernandez-Montfort
Cleveland Clinic
CardiologyCardiogenic shockHeart failureVentricular assist devicePercutaneousMedicineCirculatory system
6Publications
1H-index
1Citations
What is this?
Publications 6
Newest
#1Jaime Hernandez-Montfort (Cleveland Clinic)H-Index: 1
#2Katherine Thayer (Tufts Medical Center)
Last. Navin K. Kapur (Tufts Medical Center)H-Index: 28
view all 8 authors...
Cardiogenic shock remains a complex global health entity associated with high mortality despite increased utilization and availability of acute mechanical circulatory support (AMCS) as a bridge to replacement, recovery and/or palliation. We sought to determine the disease trajectory of patients with
Source
#2A.R. Garan (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 2
view all 12 authors...
The aim of this study was to assess the impact of gender on the presentation of cardiogenic shock (CS) and the characteristics of survivorship in male and female patients. CS is a complex and heterogeneous disease that continues to be associated with high mortality. Recent attempts have been made
Source
#1Katherine Thayer (Tufts Medical Center)
#2Elric Zweck (Tufts Medical Center)
Last. Navin K. Kapur (Tufts Medical Center)H-Index: 28
view all 8 authors...
Cardiogenic shock (CS) mortality remains unacceptably high. Risk-stratifying CS patients could improve case management and the design of future trials. Using real-world data, we tested whether the Society for Cardiovascular Angiography and Interventions (SCAI) CS Stages, drug and device escalation,
Source
#1Jaime Hernandez-Montfort (Cleveland Clinic)H-Index: 1
#2Rongbing Xie (UAB: University of Alabama at Birmingham)H-Index: 5
Last. Jennifer Cowger (HFHS: Henry Ford Health System)H-Index: 20
view all 12 authors...
Abstract Background Patients with advanced heart failure and cardiogenic shock (CS) often require temporary circulatory support (TCS) as a bridge to durable ventricular assist devices (dVAD). We aim to characterize longitudinal outcomes of patients with and without CS. Methods Between 2013 and 2017, 13,813 adult patients classified as Intermacs profiles 1-3 with CF-LVADs or BiVADs were registered into IMACS. Patients were sub-grouped according to support type (ECMO, IABP, other-TCS). Other-TCS i...
1 CitationsSource
#1Sultan Alotaibi (LSE: London School of Economics and Political Science)
#2Jaime Hernandez-Montfort (LSE: London School of Economics and Political Science)H-Index: 1
Last. Bernardo A. Perez (LSE: London School of Economics and Political Science)
view all 5 authors...
This study aims to determine whether the use of remote monitoring (RM) in implantable cardiac devices decreases all-cause mortality and heart failure (HF)-related hospitalization. We sought to conduct a systematic review and a meta-analysis of published randomized controlled studies. The population is adult patients with a diagnosis of HF with implantable devices. The intervention is RM using implantable cardiac devices whether added or used alone compared to standard of care. The outcomes are H...
Source
#1Van-Khue Ton (Harvard University)
#2Rongbing Xie (UAB: University of Alabama at Birmingham)H-Index: 5
Last. James K. Kirklin (UAB: University of Alabama at Birmingham)H-Index: 68
view all 12 authors...
Abstract Background Patients with cardiogenic shock (CS) needing temporary circulatory support (TCS) have poor survival after durable ventricular assist device (dVAD). We aimed to characterize post-dVAD adverse event burden and survival in those requiring pre-operative TCS. Method We analyzed 13,511 adults (Intermacs Profiles 1-3) with continuous flow dVADs in IMACS (2013-2017) according to need for pre-operative TCS (n=5632) versus no TCS (n=7879). Of these, 726 (5.4%) had biventricular assist ...
Source
1